New Delhi: Hyderabad-based Aurobindo Pharma will collaborate with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of the COVID-19 vaccine, it announced on Tuesday.
BIRAC has facilitated the establishment of ‘the r-VSV vaccine’ manufacturing platform for the first time in India by supporting Aurobindo Pharma’s COVID-19 vaccine development, the company said in a regulatory filing, Hindustan Times (HT) reported quoting PTI.
Aurobindo Pharma is developing a COVID-19 vaccine through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate is based on a proprietary vaccine delivery platform of the company, the report added.
“Aurobindo is in the process of setting up a state-of-art manufacturing facility for viral vaccines which will be used to produce the COVID-19 vaccine and other viral vaccines. The plant will comply with global standards. The company’s COVID-19 vaccine development is going as per plan,” the filing added.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the pharma firms in India working on the coronavirus vaccine.
Bhubaneswar: Even as BJP on Thursday expressed confidence of winning in at least 16 Lok…
Agartala: Jawans of the Tripura State Rifles (TSR), an elite counter-insurgency force, are set to…
New Delhi: While acknowledging the need for India and Canada to “get along”, Prime Minister…
Sonepur: A man has died of suspected sunstroke in Binika town of Odisha's Sonepur district.…
Bhubaneswar: Odisha FC women made history on March 24 by lifting the Indian Women’s League…
Bhubaneswar: Putting to rest all speculation about its candidate in Korei Assembly constituency for the…
New Delhi: The BJP can win 16 Lok Sabha seats in Odisha in the upcoming…
Mumbai: Serum Institute of India (SII) is facing the heat after AstraZeneca admitted in court…